IXP-RAPID Trademark

Trademark Overview


On Friday, September 18, 2015, a trademark application was filed for IXP-RAPID with the United States Patent and Trademark Office. The USPTO has given the IXP-RAPID trademark a serial number of 79180324. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 1, 2024. This trademark is owned by ImmuneXpress Pty Ltd. The IXP-RAPID trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for treating systemic inflammation associated with infection; Clinical diagnostic reagents for medical or veterinary use, namely, medical diagnostic reagents not for laboratory use; biological and chemical test reagents for clinical and medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Medical services; Medical services in the field of pathology; Medical and pathology services being the analysis of body fluid samples, namely, medical testing for diagnostic or treatment purposes; medical services being molecular diagnostic services; Medical services, namely, taking of body fluid samples of others; information, advisory and consultancy services in relation to the aforementioned

Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; Medical diagnostic testing apparatus for carrying out diagnostic tests particularly for the analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; diagnostic test apparatus in this class consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; Point of care medical devices, namely, devices for analysis of gene expression, protein expression and metabolite expression in the conditio...
ixp-rapid

General Information


Serial Number79180324
Word MarkIXP-RAPID
Filing DateFriday, September 18, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 1, 2024
Registration Number5262886
Registration DateTuesday, August 15, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements


Description of MarkThe mark consists of of the wording "IXP-RAPID".
Goods and ServicesPharmaceutical preparations and substances for treating systemic inflammation associated with infection; Clinical diagnostic reagents for medical or veterinary use, namely, medical diagnostic reagents not for laboratory use; biological and chemical test reagents for clinical and medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical services; Medical services in the field of pathology; Medical and pathology services being the analysis of body fluid samples, namely, medical testing for diagnostic or treatment purposes; medical services being molecular diagnostic services; Medical services, namely, taking of body fluid samples of others; information, advisory and consultancy services in relation to the aforementioned
Goods and ServicesSurgical and medical apparatus and instruments for use in analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; Medical diagnostic testing apparatus for carrying out diagnostic tests particularly for the analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection; diagnostic test apparatus in this class consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; Point of care medical devices, namely, devices for analysis of gene expression, protein expression and metabolite expression in the conditions of inflammation, immune-suppression, immune disorders, the presence of systemic inflammation associated with infection, and susceptibility to systemic inflammation associated with infection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 1, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 1, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 1, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmuneXpress Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressSeattle, WA 98109

Party NameImmuneXpress Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressSeattle, WA 98109

Party NameImmuneXpress Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Friday, March 1, 2024CANCELLED SECTION 71
Monday, August 15, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, December 26, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 5, 2017FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 5, 2017FINAL DISPOSITION PROCESSED
Wednesday, November 15, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Friday, July 28, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, June 23, 2017NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 7, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 7, 2017NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Saturday, May 27, 2017NOTIFICATION PROCESSED BY IB
Thursday, May 18, 2017NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, May 10, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 21, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 4, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 28, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, March 10, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 4, 2017ASSIGNED TO LIE
Thursday, February 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 23, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 23, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, February 23, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, February 10, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 16, 2016NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 2, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 2, 2016FINAL REFUSAL E-MAILED
Wednesday, November 2, 2016FINAL REFUSAL WRITTEN
Friday, August 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 23, 2016ASSIGNED TO LIE
Wednesday, July 20, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, July 19, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 5, 2016REFUSAL PROCESSED BY IB
Tuesday, January 19, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 19, 2016REFUSAL PROCESSED BY MPU
Friday, January 15, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 14, 2016NON-FINAL ACTION WRITTEN
Wednesday, January 13, 2016APPLICATION FILING RECEIPT MAILED
Saturday, January 9, 2016ASSIGNED TO EXAMINER
Saturday, January 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 7, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB